Early treatment with hepatocyte growth factor improves pulmonary artery and right ventricular remodeling in rats with pulmonary artery hypertension by modulating cytokines expression
- Author:
- No author available
- Journal Title:
- Chinese Journal of Tuberculosis and Respiratory Diseases
- Issue:
- 6
- DOI:
- 10.3760/cma.j.issn.1001-0939.2014.06.009
- Key Word:
- 高血压,肺性;心室重塑;细胞因子类;肝细胞生长因子;Pulmonary artery hypertension;Ventricular remodeling;Cytokines;Hepatocyte growth factor
Abstract： Objective To investigate the effect of early treatment with hepatocyte growth factor (HGF) on the cytokine expression and pulmonary artery,right ventricular (RV) remodeling in the rat model of pulmonary artery hypertension (PAH).Methods The rat model of PAH was produced by injecting monocrotaline,and the model rats were randomly divided into empty adenovirus transfection group (MCT group,n =10) and HGF gene transfection group(HGF group,n =10).Another group of rats served as the Sham operation group (Sham group n =10).After 4 weeks of HGF gene transfection,the histological sections of the lungs and right ventricular (RV) were stained with hematoxylin-eosin (HE) and the pulmonary artery and RV remodeling were examined.The rat lung sections were also immunostained with antibodies against factor Ⅷ,and the capillary density were calculated.Meanwhile,the mRNA expression of TNF-α,IL-6,IL-1β and TGF-β1 in pulmonary arteries and RV were detected by RT-PCR.Results HGF gene treatment significantly decreased the ratio of vessel wall thickness to pulmonary artery diameter and the ratio of vessel wall area to total area,and increased the capillary density of lung in PAH rats.HGF gene treatment also significantly decreased cross-sectional area of cardiomyocytes and collagen deposited in RV.Moreover,HGF gene treatment significantly decreased the expression of cytokines in pulmonary artery (TNF-α:0.82 ± 0.07 vs 0.49 ± 0.09,IL-6:1.13 ± 0.19 vs 0.68 ± 0.09,IL-1 β:0.86 ± 0.11 vs 0.51 ±0.07,TGF-β1:1.18 ± 0.12 vs 0.59 ± 0.10) and RV (TNF-α:0.79 ± 0.11 vs 0.48 ± 0.08,IL-6:1.03 ±0.11vs0.63±0.09,IL-1β:0.81±0.11 vs 0.52±0.07,TGF-β1:0.94 ±0.12 vs0.53±0.10) in MCT induced PAH rats (P ＜ 0.05).Conclusion Early treatment with HGF improves pulmonary artery and RV remodeling,possibly by decreasing the expression of TNF-α,IL-6,IL-1β and TGF-β1 in pulmonary arteries and RV.
- [1]王伟,张芳,谢悦,等.外源性HGF基因转染对肺动脉高压兔肺血流灌注及肺动脉压力的影响[J].2011,(11).
- [2]Shahzad G, Raja,Shahbaz M, Raja.Treating pulmonary arterial hypertension: current treatments and future prospects.[J].2011,2.
- [3]F L, Bellisarii,S, Gallina,R, De Caterina.Tumor necrosis factor-alpha and cardiovascular diseases.[J].2001,2(6).
- [4]Jung Hyun, Kwon,Kwan Chang, Kim,Min-Sun, Cho,etc.An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model.[J].2013,56(3).
- [5]Geiser T,Fachinger P,van-Leer C,etc.Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis.[J].2007,292(2).
- [6]R M, Tuder,B, Groves,D B, Badesch,etc.Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.[J].1994,144.
- [7]Teruya, Nakamura,Kunio, Matsumoto,Shinya, Mizuno,etc.Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts.[J].2005,288(5).
- [8]Bogaard HJ,Vonk-Noordegraaf A,Voelkel NF,etc.The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension.[J].2009,135(3).
- [9]Mats I,Zingerman B,Ben-Dayan D,etc.Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of right ventricular function with functional capacity and to predict outcome.[J].2007,23(2).
- [10]Matsumoto K,Nakamura T,Mizuno S,etc.Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.[J].1998,101(9).
- [11]Yasunobu Matsuda,Kunio Matsumoto,Toshikazu Nakamura,etc.Hepatocyte Growth Factor Suppresses the Onset of Liver Cirrhosis and Abrogates Lethal Hepatic Dysfunction in Rats[J].1995,118(3).
- [12]Naeije,R.,Kerbaul,F.,Brimioulle,S.,etc.Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure[J].2012,33(8).